Product

Genvoya

Aliases

elvitegravir/cobicistat/emtricitabine/ tenofovir alafenamide

2 clinical trials

2 indications

Indication

HIV-1 infection

Indication

Healthy Control Participants

Clinical trial

Open Label, Randomized (1:1) Clinical Trial to Evaluate Switching From Dual Regimens Based on Dolutegravir Plus a Reverse Transcriptase Inhibitor to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed, HIV-1 Infected Patients (Be-OnE Study).

Status: Terminated, Estimated PCD: 2018-03-20

Clinical trial

Bioequivalence of Crushed and Whole Genvoya Tablets (Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Fumarate)

Status: Completed, Estimated PCD: 2021-11-01